|
1
|
Nicholson AG, Tsao MS, Beasley MB, Borczuk
AC, Brambilla E, Cooper WA, Dacic S, Jain D, Kerr KM, Lantuejoul S,
et al: The 2021 WHO classification of lung tumors: Impact of
advances since 2015. J Thorac Oncol. 17:362–387. 2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Min BH, Tae CH, Ahn SM, Kang SY, Woo SY,
Kim S and Kim KM: Epstein-Barr virus infection serves as an
independent predictor of survival in patients with
lymphoepithelioma-like gastric carcinoma. Gastric Cancer.
19:852–859. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Qiu ZX, Zhou P and Wang K: Primary
pulmonary lymphoepithelioma-like carcinoma response favorably to
nivolumab: A case report. Onco Targets Ther. 12:8595–8600.
2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Pang LL, Liao J, Huang YH, Gan JD, Zhuang
WT, Lv Y, Liang WT, Zhang L and Fang WF: Exploration of
immunotherapy in advanced pulmonary lymphoepithelioma-like
carcinoma. Int J Cancer: Jan 11, 2023 (Epub ahead of print).
|
|
5
|
Hao Y, Zhang X and Yu L: Immune checkpoint
inhibitor-related pneumonitis in non-small cell lung cancer: A
review. Front Oncol. 12(911906)2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Suresh K, Naidoo J, Lin CT and Danoff S:
Immune checkpoint immunotherapy for non-small cell lung cancer:
Benefits and pulmonary Toxicities. Chest. 154:1416–1423.
2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Reuss JE, Suresh K and Naidoo J:
Checkpoint inhibitor pneumonitis: Mechanisms, characteristics,
management strategies, and beyond. Curr Oncol Rep.
22(56)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lin X, Lu T, Li S, Xie X, Chen X, Jiang J,
Qin Y, Xie Z, Liu M, Ouyang M, et al: Cytomegalovirus infection as
an underestimated trigger for checkpoint inhibitor-related
pneumonitis in lung cancer: A retrospective study. Clin Transl
Oncol. 23:389–396. 2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Tan PS, Aguiar P Jr, Haaland B and Lopes
G: Comparative effectiveness of immune-checkpoint inhibitors for
previously treated advanced non-small cell lung cancer-A systematic
review and network meta-analysis of 3024 participants. Lung Cancer.
115:84–88. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Saikawa H, Nagashima H, Maeda T and
Maemondo M: Acute cerebellar ataxia due to Epstein-Barr virus under
administration of an immune checkpoint inhibitor. BMJ Case Rep.
12(e231520)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Pugh MR, Leopold GD, Morgan M, Christian
AD, Hewett R, Durai D, Wagstaff J, Harris D and Dojcinov SD:
Epstein-Barr virus-positive mucocutaneous ulcers complicate colitis
caused by immune checkpoint regulator therapy and associate with
colon perforation. Clin Gastroenterol Hepatol. 18:1785–1795 e3.
2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yin J, Wu Y, Yang X, Gan L and Xue J:
Checkpoint inhibitor pneumonitis induced by Anti-PD-1/PD-L1 therapy
in non-small-cell lung cancer: Occurrence and Mechanism. Front
Immunol. 13(830631)2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lin X, Deng H, Chen L, Wu D, Chen X, Yang
Y, Chen T, Xie X, Xie Z, Liu M, et al: Clinical types of checkpoint
inhibitor-related pneumonitis in lung cancer patients: A
multicenter experience. Transl Lung Cancer Res. 10:415–429.
2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Fedorov VD, Themeli M and Sadelain M:
PD-1- and CTLA-4-based inhibitory chimeric antigen receptors
(iCARs) divert off-target immunotherapy responses. Sci Transl Med.
5:172ra–215ra. 2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Mcgranahan N, Furness AJ, Rosenthal R,
Ramskov S, Lyngaa R, Saini SK, Jamal-Hanjani M, Wilson GA, Birkbak
NJ, Hiley CT, et al: Clonal neoantigens elicit T cell
immunoreactivity and sensitivity to immune checkpoint blockade.
Science. 351:1463–1469. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Subudhi SK, Aparicio A, Gao J, Zurita AJ,
Araujo JC, Logothetis CJ, Tahir SA, Korivi BR, Slack RS, Vence L,
et al: Clonal expansion of CD8 T cells in the systemic circulation
precedes development of ipilimumab-induced toxicities. Proc Natl
Acad Sci USA. 113:11919–11924. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Johnson DB, Mcdonnell WJ,
Gonzalez-Ericsson PI, Al-Rohil RN, Mobley BC, Salem JE, Wang DY,
Sanchez V, Wang Y, Chastain CA, et al: A case report of clonal
EBV-like memory CD4(+) T cell activation in fatal checkpoint
inhibitor-induced encephalitis. Nat Med. 25:1243–1250.
2019.PubMed/NCBI View Article : Google Scholar
|
